Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices
Contract Research & Services
Clinical Trials
Return to: PBR Home | Contract Research & Services | Clinical Trials

Clinical Trials

Xenetic completes dosing patients in Phase II MyeloXen trial to treat multiple sclerosis By PBR Staff Writer
Xenetic Biosciences' license partner Pharmsynthez has completed dosing patients in its Phase II clinical trial with MyeloXen to treat relapsing remitting and secondary progressive (RRSP) multiple sclerosis (MS).
Contract Research & Services > Clinical Trials > News
Intra-Cellular Therapies reports positive results from Phase I/II ITI-007 trial By PBR Staff Writer
Intra-Cellular Therapies has released additional results from ITI-007-200, a Phase I/II clinical trial of its lead drug candidate, ITI-007, in healthy geriatric subjects (trial Part 1) and in patients with dementia, including Alzheimer's disease (trial Part 2).
Contract Research & Services > Clinical Trials > News Neurotrope doses last Alzheimer's disease patient in Phase IIa trial of Bryostatin-1 By PBR Staff Writer
Neurotrope has dosed the last patient in its Phase IIa clinical trial of Bryostatin-1, a potent modulator of the enzyme protein kinase C epsilon (PKCe), to treat Alzheimer's disease (AD).
Contract Research & Services > Clinical Trials > News
See more Clinical Trials news

Latest Clinical Trials News and Insight

View all Clinical Trials news or find news targeted to your interests
Otologic starts Phase I HNPN-1010 trial to treat hearing disorders
By PBR Staff Writer
Otologic Pharmaceutics (OPI) has initiated a Phase I clinical trial of its lead product candidate HNPN-1010 to treat acute sensorineural hearing loss.
Contract Research & Services > Clinical Trials > News
Catch a Wave and You’re Sitting on Top of the World:How Information Technology is Leveling the Playing Field
| By Merge eClinical
Some 50 years ago, The Beach Boys offered up this observation: “Catch a wave and you’re sitting on top of the world.” They may have been singing about the virtues of surfing, but the refrain is applicable to a lot more than just hanging 10. It is no surprise that since 2000, there’s been a tidal wave of information technology advancements that’s been gathering size, speed and intensity. This wave has fundamentally reshaped how, when and where we communicate and conduct business.
Contract Research & Services > Clinical Trials > White Papers
Achieving Cost and Process Efficiencies with Online Endpoint Coordination and Adjudication
| By Merge eClinical
Clinical trials increasingly rely on endpoint adjudication to better assess patient events and provide standardised endpoint classifications. The increased trend toward the use of endpoint adjudication in a wider variety of clinical trials is being driven by regulatory, clinical, business and technology trends:
Contract Research & Services > Clinical Trials > White Papers
eClinicalOS™ (eCOS)
eClinicalOS™ (eCOS) from Merge eClinical is a single, scalable cloud-based platform that lets clinical research professionals design, launch and manage studies with more control, convenience and confidence than ever before. With headquarters in Research Triangle Park, N.C., and offices around the globe, Merge eClinical serves researchers in all industry categories: pharmaceutical and device manufacturers, CROs and academic institutions. Through active sites in 80-plus countries, more than 50,000 clinical research professionals in small and large organizations have entrusted their data and study management needs to our flagship product, eCOS.
Contract Research & Services > Clinical Trials > Products
Eurotrials Selects Merge eClinical as Clinical Research Technology Partner
Partnership strengthens presence in European and Latin American markets; Merge eClinical Solutions expand footprint to open data centre in Brazil.
Contract Research & Services > Clinical Trials > Press Releases
System Features
Want to learn more about eClinicalOS (eCOS) but don’t have a lot of time right now? No worries. That’s one of the great things about the system: One glance tells you everything you need to know.
Contract Research & Services > Clinical Trials > Case Studies
Verthermia Selects eClinicalOS(R) for Whole Body Hyperthermia Ovarian Cancer Treatment Trial
Verthermia, Inc. has selected the Merge eClinicalOS data management platform from Merge eClinical for its clinical trial exploring the potential of whole body hyperthermia as a standalone treatment for women with Stage III or IV ovarian cancer.
Contract Research & Services > Clinical Trials > Press Releases
Optional Modules and Services
With eClinicalOS (eCOS) from Merge eClinical, you can choose from a range of options to help you see your study more clearly — and manage it more smartly. Through our exclusive Clinical Confi gurator™, you simply click-andpick the capabilities that best fi t your research needs. So you get what you need — without having to pay for what you don’t.
Contract Research & Services > Clinical Trials > Case Studies
Product Brochure
There are phones, and then there are smart phones. There are cars, and then there are smart cars. There’s research, and now there’s smart research. That’s where we come in. Welcome to eClinicalOS.
Contract Research & Services > Clinical Trials > Case Studies
Galena Biopharma closes enrollment in Phase II trial of GALE-401
By PBR Staff Writer
US-based Galena Biopharma has completed patient enrollment in the GALE-401, or Anagrelide Controlled Release, Phase II clinical trial to treat patients with elevated platelet counts in myeloproliferative neoplasms (MPNs).
Contract Research & Services > Clinical Trials > News
View all Clinical Trials news or find news targeted to your interests

Buy the latest industry research online today!
Shire Plc : Pharmaceuticals & Healthcare - Company Profile, SWOT & Financial Report 03 October 2013 This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $250